Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
10 papers
Recent·Most cited
A. N. Honko, R. Hunegnaw, J. I. Moliva, A. Ploquin, C. N. M. Dulan, T. Murray, D. Carr, K. E. Foulds, J. B. Geisbert, T. W. Geisbert, J. C. Johnson, S. E. Wollen-Roberts, J. C. Trefry, D. A. Stanley, N. J. Sullivan
A single dose of ChAd3-SUDV vaccine protected macaques from lethal SUDV challenge via parenteral and aerosol routes.
bioRxiv · Feb 7, 2024 · PreprintImmunology
C. Woolsey, R. W. Cross, K. N. Agans, V. Borisevich, D. J. Deer, J. B. Geisbert, C. Gerardi, T. E. Lantham, K. A. Fenton, M. Egan, J. H. Eldridge, T. W. Geisbert, D. Matassov
This paper shows a highly attenuated rVSV-based vaccine protects nonhuman primates against lethal Marburg virus challenge when administered up to 1 week before exposure.
bioRxiv · Jan 22, 2022Microbiology
E. Kuang, R. W. Cross, M. McCavitt-Malvido, D. M. Abelson, V. Borisevich, K. N. Agans, N. Mlakar, A. Marimuthu, D. J. Deer, W. S. Shestowsky, D. Kim, J. B. Geisbert, L. Zeitlin, C. L. Moyer, C. J. Roy, , Z. A. Bornholdt
This study shows that a single intramuscular dose of MBP431, a modified ebolavirus therapeutic, can reverse disease and provide protection in non-human primates.
bioRxiv · Jan 6, 2022Microbiology
R. W. Cross, A. N. Prasad, C. Woolsey, K. N. Agans, V. Borisevich, N. S. Dobias, J. E. Comer, D. J. Deer, J. B. Geisbert, A. Rasmussen, W. I. Lipkin, K. A. Fenton, T. W. Geisbert
This study examines the natural history of Ebola virus infection in nonhuman primates after conjunctival exposure, finding that lower doses result in delayed disease and reduced mortality.
bioRxiv · Dec 29, 2021Microbiology
R. Hunegnaw, A. Honko, L. Wang, D. Carr, T. Murray, W. Shi, C. N. M. Dullan, K. E. Foulds, K. N. Agans, R. W. Cross, J. B. Geisbert, T. W. Geisbert, C. Cheng, A. Ploquin, D. A. Stanley, , N. J. Sullivan
A single-shot ChAd3-MARV vaccine provided rapid and durable protection against lethal Marburg virus infection in macaques, with antigen-specific antibodies correlating strongly with immunity.
bioRxiv · Dec 22, 2021 · PreprintImmunology
P. Gilchuk, C. D. Murin, R. W. Cross, P. A. Ilinykh, K. Huang, N. Kuzmina, V. Borisevich, K. N. Agans, J. B. Geisbert, R. H. Carnahan, R. S. Nargi, R. E. Sutton, N. Suryadevara, S. J. Zost, R. G. Bombardi, , J. E. Crowe
This paper develops a therapeutic cocktail of two human antibodies that protect against multiple ebolaviruses in non-human primates and reveals their molecular mechanisms.
bioRxiv · May 2, 2021 · PreprintImmunology
r. cross, A. N. Prasad, V. Borisevich, C. Woolsey, K. N. Agans, D. J. Deer, N. S. Dobias, J. B. Geisbert, K. A. Fenton, T. W. Geisbert
This study shows that convalescent sera with high neutralizing antibody titers reduce SARS-CoV-2 viral load and disease severity in African green monkeys.
bioRxiv · Oct 14, 2020Microbiology
C. B. Woolsey, V. Borisevich, A. N. Prasad, K. N. Agans, D. J. Deer, N. S. Dobias, J. C. Heymann, S. L. Foster, C. B. Levine, L. Medina, K. Melody, J. B. Geisbert, K. A. Fenton, T. W. Geisbert, R. W. Cross
This study establishes an African green monkey model for COVID-19, showing high SARS-CoV-2 replication and severe respiratory disease with lower viral doses than in other NHP species.
bioRxiv · May 17, 2020 · PreprintMicrobiology
R. W. Cross, Z. A. Bornholdt, A. N. Prasad, J. B. Geisbert, V. Borisevich, K. N. Agans, D. J. Deer, K. Melody, K. A. Fenton, H. Feldmann, A. Sprecher, T. W. Geisbert
bioRxiv · Apr 1, 2020Microbiology
Z. A. Bornholdt, A. S. Herbert, C. E. Mire, S. He, R. W. Cross, A. Z. Wec, D. M. Abelson, J. B. Geisbert, R. M. James, M. N. Rahim, W. Zhu, V. Borisevich, L. Banadyga, B. M. Gunn, K. N. Agans, , J. M. Dye
This paper demonstrates that a two-antibody cocktail (MBP134AF) provides broad therapeutic protection against multiple ebolaviruses in ferrets and nonhuman primates.
bioRxiv · Aug 19, 2018Microbiology